Patents
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
07/2003
07/31/2003WO2002068421A3 Tricyclic compounds and their analogs as inhibitors of cytokine signaling
07/31/2003US20030144562 Hetero diels-alder adducts of pentacene as soluble precursors of pentacene
07/31/2003US20030144504 Dialkyl-halogenophenyl-substituted ketoenols
07/31/2003US20030144331 p53 inhibitors and therapeutic use of the same
07/31/2003US20030144294 Antiproliferative or anticarcinogenic agents comprising reaction products of ninhydrin or benzo(f)ninhydrin with 1,5-diaminotetrazole; enzyme inhibitors
07/31/2003US20030144274 Preferential enzyme inhibitors such as 3-(4-Methoxyphenyl)-prop-1-ynyl)-N-(4-carboxybenzyl)benzamide, used for prophylaxis of degenerative diseases including cancer and arthritis
07/31/2003CA2472682A1 Treating stress response with chemokine receptor ccr5 modulators
07/30/2003CN1433411A Chemical compounds
07/30/2003CN1116301C Tetracyclic fluoquinolone carboxylic acid, its preparing process and medicinal composition containing it as active component
07/30/2003CN1116300C Tetracyclic fluoquinolone carboxylic acid, its preparing process and medicinal composition containing it as active component
07/29/2003US6600035 6-(substituted methylene) penems and intermediates
07/24/2003WO2003060078A2 Heterocyclic modulators of nuclear receptors
07/24/2003WO2003059356A2 Novel anti-infectives
07/24/2003WO2003059289A2 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
07/24/2003US20030139393 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
07/24/2003US20030139390 Compounds for the modulation of PPARgamma activity
07/24/2003US20030136964 Thin film transistors using solution processed pentacene precursor as organic semiconductor
07/24/2003CA2472470A1 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
07/23/2003EP1228073B1 Imidazole compounds used as phosphodiesterase vii inhibitors
07/22/2003US6596726 Method of inhibiting epidermal growth factor by treating, with an effective inhibiting amount, a mammal, in need thereof inhibit the epidermal growth factor receptor and related receptors and, in particular, their tyrosine kinase enzyme
07/17/2003WO2003057672A2 Tetrahydroquinoline analogues as muscarinic agonists
07/17/2003WO2003057254A1 Preventives/remedies for urinary disturbance
07/17/2003US20030134840 Novel compounds
07/17/2003US20030134148 Red fluorescent dyes having high fluorescent strength and high color purity; high luminance; high efficacy by low voltage-driving; stability; durability; color conversion filter, pulp dyeing; photographic dye; sensitizers
07/17/2003CA2471760A1 Preventives/remedies for urinary disturbance
07/16/2003EP1326856A1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity
07/16/2003EP1326841A1 Pyridinone derivatives for treatment of atherosclerosis
07/16/2003EP1054669B1 Use of thiadiazolo[4,3-a]pyridine derivatives
07/16/2003CN1430615A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/16/2003CN1430614A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/16/2003CN1430610A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
07/16/2003CN1114402C Isothiazolones compound, preparation containing them and its use
07/15/2003US6593353 p53 inhibitors and therapeutic use of the same
07/15/2003US6593013 Electroluminescence device, cyclic azine compound and production process of cyclic azine dye
07/10/2003WO2003055478A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
07/10/2003US20030130287 Psychological disorders; central nervous system disorders; antidepressants; Parkinson's disease; Alzheimer's disease;cardiovascular disorders
07/10/2003US20030130281 DPP IV inhibitors
07/10/2003US20030130261 Central nervous system disorders; psychological disorders; inflammatory bowel disorders
07/10/2003US20030130260 Aryl fused azapolycyclic compounds
07/10/2003US20030130257 Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
07/09/2003EP1325910A1 Aliphatic nitrogenous five-membered ring compounds
07/09/2003EP1325009A2 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same
07/09/2003EP1325006A2 Heterocyclic compounds as ligands of the gaba a? receptor
07/09/2003EP1324993A2 Substituted 1,4-thiazepine and analogs as activators of caspases and inducers of apoptosis and the use thereof
07/09/2003EP0966490B1 Catalyst compositions for the polymerization of olefins
07/09/2003CN1113875C Substituted aromatic thiocarboxylic acid amides and their use as herbicides
07/08/2003CA2153549C New benzothiadiazine derivative, process for preparing the same and pharmaceutical compositions containing said derivative
07/03/2003WO2003053979A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same
07/03/2003WO2003053978A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same
07/03/2003WO2003053944A1 Pancreatic lipase inhibitor compounds, their synthesis and use
07/03/2003WO2003053435A1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
07/03/2003WO2003053433A1 Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
07/03/2003WO2003053358A2 Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
07/03/2003WO2003053344A2 Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
07/03/2003US20030125575 Process for the preparation of(R)-2-bromo-3-phenyl -propionic acid
07/03/2003US20030125562 Functionalized 4-imino-3-mercapto-1,2,4-triazoles as inhibitors of nitric oxide synthase (NOS) and as inhibitors of malignant cell growth
07/03/2003CA2471263A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same
07/03/2003CA2471120A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same
07/03/2003CA2471098A1 Pancreatic lipase inhibitor compounds, their synthesis and use
07/03/2003CA2470964A1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
07/02/2003EP1323710A1 Nitrogenous five-membered ring compounds
07/02/2003EP1322598A1 Nitroso diphenylamine derivatives
07/01/2003US6586604 Tricyclic amine derivatives
07/01/2003US6586430 Administering azabicyclo compounds to treat human immunodeficiency virus infections and respiratory system disorders
07/01/2003US6586429 For treatment of chronic inflammatory disease, chronic intestinalinflammation, arthritis, psoriasis, asthma, autoimmune disorders
06/2003
06/26/2003WO2003051890A1 Imidazo [2,1-b]-1,3,4-thiadiazole suflonamides
06/26/2003WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051840A1 Pyrrolidine and piperidine derivates as nk1 antagonists
06/26/2003WO2003051300A2 Metal complexes and formulations of rifamycin analogues and uses therof
06/26/2003WO2003051299A2 Sulfhydryl rifamycins and uses thereof
06/26/2003US20030120066 Synthetic peptides
06/26/2003US20030119842 Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines
06/26/2003CA2469953A1 Imidazo [2,1-.beta.]-1,3,4-thiadiazole sulfonamides
06/26/2003CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/25/2003EP1235792A4 Preparation of [4s-(4alpha,7alpha,10abeta)]-4-amino-octahydro-5-oxo-7h-pyrido 2,1-b] 1,3]thiazepine-7-carboxylic acid, methyl ester and salts thereof via novel disulfides
06/25/2003EP0641343B1 4-mercaptoacetylamino-[2] benzazepinone(3) derivatives, and use as enkephalinase inhibitors
06/25/2003CN1425669A Tetracyclic fluoroquinolone carboxylic acid, its preparing method and medicinal composition with it as active component
06/25/2003CN1425668A Tetracyclic fluoroquinolone carboxylic acid, its preparin method and medicinal composition with it as active component
06/25/2003CN1112363C Bicyclic pyrimidine derivatives and their use as anti-coagulants
06/24/2003US6583296 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and α-1-blocking action
06/24/2003US6583290 14-methyl epothilone derivatives
06/24/2003US6583146 Thiazolopyrimidine compounds, its production and use
06/24/2003US6583138 Mediators or antagonists of the effects of histamine, leukotriene and the like; heterocyclic ring condensed benzothiazine compounds; inhibit the activation of the tyrosine kinase of 72 kDa
06/19/2003WO2003049679A2 Mitotic kinesin inhibitors
06/19/2003US20030114485 Killing drug resistant cancer cells; controlling cell differentiation
06/19/2003US20030113755 Fluorescent nucleotides and labeling methods using the same
06/19/2003CA2468156A1 Azolopyrimidinone compounds and their use
06/18/2003EP1319010A1 Tricyclic mercaptomethyl-substituted 2,3-dihydro-quinazolin-5-ones and 2,3-dihydro-benzo-[1,2,4]-thiadiazin-5,5-dioxides as matrix metalloproteinase (mmp) inhibitors
06/18/2003EP1318997A1 Pyrazole compounds useful as protein kinase inhibitors
06/18/2003EP1318814A2 Triazole compounds useful as protein kinase inhibitors
06/18/2003EP1015451B1 Tetrahydro gamma-carbolines
06/17/2003US6579882 Cell adhesion-inhibiting antiinflammatory compounds
06/17/2003US6579881 Muscle relaxants, antiserotonine agent
06/14/2003CA2364985A1 Imidazo(2,1-b)thiadiazole sulfonamides
06/12/2003WO2003048127A1 Aromatic heterocyclic non-covalent inhibitors of urokinase and blood vessel formation
06/12/2003WO2003048123A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
06/12/2003WO2003048109A1 Novel glucagon antagonists
06/12/2003WO2002046199A8 Process and ester derivatives useful for preparation of cephalosporins
06/12/2003US20030109535 GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure:prodrugs, stereoisomers and drugs
1 ... 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 ... 152